Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.

Saved in:
Bibliographic Details
Title: Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
Authors: Kim D; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Sim NS; Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Woo S; Department of Life Science, CHA University, Seongnam, Korea., Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Lee CK; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Hong SS; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Kim SH; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Hwang HK; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Kang CM; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Lee WJ; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Jo JH; Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Chung T; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea., Hwang S; Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Kang B; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Kim JS; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Kwon CI; Digestive Disease Center, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Kim S; Department of Biomedical Systems Informatics and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea., Chon HJ; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Kim CG; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Park YN; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea., Choi HJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2026 Apr; Vol. 32 (2), pp. 721-736. Date of Electronic Publication: 2025 Dec 26.
Publication Type: Journal Article
Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2287-285X
DOI:10.3350/cmh.2025.1019